共 50 条
Association Between Tp-e/QT Ratio and Prognosis in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
被引:134
|作者:
Zhao, Xiangmei
[1
]
Xie, Zhouliang
[2
]
Chu, Yingjie
[1
]
Yang, Lei
[1
]
Xu, Wenkai
[1
]
Yang, Xianzhi
[1
]
Liu, Xiaoyu
[1
]
Tian, Lixiao
[1
]
机构:
[1] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Emergency, Zhengzhou 450003, Peoples R China
[2] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Cardiac Surg, Zhengzhou 450003, Peoples R China
关键词:
LONG QT SYNDROME;
CORRECTED QT;
END INTERVAL;
TRANSMURAL DISPERSION;
RISK STRATIFICATION;
INDEX;
PEAK;
WAVE;
REPOLARIZATION;
D O I:
10.1002/clc.22022
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: Both the Tpeak-Tend interval (Tp-e) and the Tp-e/QT ratio have been linked to increased risk for arrhythmia. Patient Tp-e/QT ratios were investigated prior to primary percutaneous coronary intervention (pPCI) in patients with ST-segment elevation myocardial infarction (STEMI). Hypothesis: Tp-e/QT ratio maybe asscioated with the prognosis in patients with ST-segment elevation. Methods: A total of 338 patients (N = 338) with STEMI treated by pPCI were included. The Tp-e and Tp-e/QT ratio were determined using electrocardiograms in the subjects exhibiting ST-segment elevation. Results: The Tp-e/QT ratio was correlated with both short- and long-term outcomes. Analysis of the receiver operating characteristic curve demonstrated that the optimal cutoff value for outcome prediction was a Tp-e/QT ratio of 0.29. Of the 388 patients enrolled, 115 (34.0%) exhibited a Tp-e/QT ratio =0.29. Patients with a Tp-e/QT ratio =0.29 showed elevated rates of both in-hospital death (21.9% vs 2.3%; P < 0.001) and main adverse cardiac events (MACE) (48.1% vs 15.3%; P < 0.005). After discharge, Tp-e/QT ratios =0.29 remained an independent predictor of all-cause death (35.5% vs 5.2%, P < 0.001) and cardiac death (32.3% vs 2.6%, P < 0.001). Conclusions: The Tp-e/QT ratio may serve as a prognostic predictor of adverse outcomes after successful pPCI treatment in STEMI patients. Clin. Cardiol. 2012 doi: 10.1002/clc.22022 This work was supported by grants from the Henan Provincial People's Hospital. The authors have no other funding, financial relationships, or conflicts of interest to disclose.
引用
收藏
页码:559 / 564
页数:6
相关论文